232 related articles for article (PubMed ID: 6589045)
1. Multiple forms and fragments of cytosolic glucocorticoid receptors from human leukemic cells and normal lymphocytes.
Sherman MR; Stevens YW; Tuazon FB
Cancer Res; 1984 Sep; 44(9):3783-96. PubMed ID: 6589045
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of labile glucocorticoid-receptor complexes from acute nonlymphocytic leukemia cells by a factor from chronic lymphocytic leukemia cells.
Holbrook NJ; Bloomfield CD; Munck A
Cancer Res; 1984 Jan; 44(1):407-14. PubMed ID: 6690056
[TBL] [Abstract][Full Text] [Related]
3. Analysis of activated and nonactivated cytoplasmic glucocorticoid-receptor complexes from human leukemia cells by rapid DNA-diethylaminoethyl minicolumn chromatography.
Holbrook NJ; Bloomfield CD; Munck A
Cancer Res; 1983 Sep; 43(9):4478-82. PubMed ID: 6871878
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid-resistant human acute lymphoblastic leukemic cell line with functional receptor.
Zawydiwski R; Harmon JM; Thompson EB
Cancer Res; 1983 Aug; 43(8):3865-73. PubMed ID: 6134583
[TBL] [Abstract][Full Text] [Related]
5. Triamcinolone acetonide 21-oic acid methyl ester: a potent local antiinflammatory steroid without detectable systemic effects.
Gorsline J; Bradlow HL; Sherman MR
Endocrinology; 1985 Jan; 116(1):263-73. PubMed ID: 3855256
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical differences between glucocorticoid-binding components from the corticoid-sensitive and -resistant strains of mouse lymphoma P1798.
Stevens J; Stevens YW
Cancer Res; 1979 Oct; 39(10):4011-21. PubMed ID: 476639
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cytosolic and nuclear glucocorticoid-binding components in human leukemic lymphocytes.
Stevens J; Stevens YW; Rosenthal RL
Cancer Res; 1979 Dec; 39(12):4939-48. PubMed ID: 498119
[No Abstract] [Full Text] [Related]
8. Comparison of in vivo activation of triamcinolone acetonide- and RU 38486-receptor complexes in the CEM-C7 and IM-9 human leukemic cell lines.
Schmidt TJ
Cancer Res; 1989 Aug; 49(16):4390-5. PubMed ID: 2743328
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid receptor determinations in leukemia patients using cytosol and whole-cell assays.
Iacobelli S; Natoli V; Longo P; Ranelletti FO; De Rossi G; Pasqualetti D; Mandelli F; Mastrangelo R
Cancer Res; 1981 Oct; 41(10):3979-84. PubMed ID: 7285007
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of glucocorticoid receptors in human leukemia.
Lippman ME; Yarbro GK; Leventhal BG
Cancer Res; 1978 Nov; 38(11 Pt 2):4251-6. PubMed ID: 308841
[TBL] [Abstract][Full Text] [Related]
11. Structure, dissociation, and proteolysis of mammalian steroid receptors. Multiplicity of glucocorticoid receptor forms and proteolytic enzymes in rat liver and kidney cytosols.
Sherman MR; Moran MC; Tuazon FB; Stevens YW
J Biol Chem; 1983 Sep; 258(17):10366-77. PubMed ID: 6885785
[TBL] [Abstract][Full Text] [Related]
12. Characterization of glucocorticoid-specific binding in the L2C leukemia.
Ruh MF; Germain CJ; Nadel EM; Ruh TS
Cancer Res; 1981 Jan; 41(1):138-43. PubMed ID: 6934847
[TBL] [Abstract][Full Text] [Related]
13. Identification of human leukemic glucocorticoid receptors using affinity labeling and anti-human glucocorticoid receptor antibodies.
Harmon JM; Eisen HJ; Brower ST; Simons SS; Langley CL; Thompson EB
Cancer Res; 1984 Oct; 44(10):4540-7. PubMed ID: 6331880
[TBL] [Abstract][Full Text] [Related]
14. Modulator inhibits nuclear translocation of the glucocorticoid receptor and inhibits glucocorticoid-induced apoptosis in the human leukemic cell line CEM C-7.
Robertson NM; Bodine PV; Hsu TC; Alnemri ES; Litwack G
Cancer Res; 1995 Feb; 55(3):548-56. PubMed ID: 7834624
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical differences between glucocorticoid receptors from corticoid-sensitive and -resistant malignant lymphocytes.
Stevens J; Eisen HJ; Stevens YW; Haubenstock H; Rosenthal RL; Artishevsky A
Cancer Res; 1981 Jan; 41(1):134-7. PubMed ID: 7448753
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor cleavage and plasminogen activation by enzymes in human breast tumor cytosol.
Sherman MR; Tuazon FB; Miller LK
Endocrinology; 1980 Jun; 106(6):1715-27. PubMed ID: 6989588
[TBL] [Abstract][Full Text] [Related]
17. Covalent labeling of rat thymocyte and human lymphoid glucocorticoid receptor.
Foster CM; Eisen HJ; Bloomfield CD
Cancer Res; 1983 Nov; 43(11):5273-7. PubMed ID: 6577947
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid receptors and in vitro responses to glucocorticoid in acute nonlymphocytic leukemia.
Crabtree GR; Bloomfield CD; Smith KA; McKenna RW; Peterson BA; Hildebrandt L; Munck A
Cancer Res; 1981 Nov; 41(11 Pt 2):4853-6. PubMed ID: 7296546
[TBL] [Abstract][Full Text] [Related]
19. Purification of the unactivated glucocorticoid receptor and its subsequent in vitro activation.
Grandics P; Miller A; Schmidt TJ; Mittman D; Litwack G
J Biol Chem; 1984 Mar; 259(5):3173-80. PubMed ID: 6699012
[TBL] [Abstract][Full Text] [Related]
20. "Defective" receptors in steroid-resistant conditions may be proteolytic artifacts.
Sherman MR; Tuazon FB; Stevens YW; Carlino JA; Niu EM
Adv Exp Med Biol; 1986; 196():23-51. PubMed ID: 3012978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
